General Meeting

Proposed transaction with Pfizer, Inc to form a new Consumer Healthcare Joint Venture

At a General Meeting held on Wednesday 8 May 2019 at the Sofitel London Heathrow Terminal 5, London Heathrow Airport, TW6 2GD  shareholders approved  the proposed transaction with Pfizer, Inc to form a new Consumer Healthcare Joint Venture. The voting results can be found here. The Circular to Shareholders and Notice of General Meeting (PDF - 392.6KB) gives details on the resolution put to the meeting, together with explanatory notes.

Previously published documents relating to the proposed transaction:

• Read the GSK press release dated 19 December 2018

Analyst call dated 19 December 2018:                                                 

• View the slides (PDF)
• View the transcript (PDF)

In accordance with section 311A of the Companies Act 2006, GSK confirms that, as at 1 April 2019, its issued share capital (excluding Treasury shares) consisted of 4,987,659,065 ordinary shares of 25 pence each, carrying one vote each. Therefore, the total voting rights that members are entitled to exercise at the AGM in respect of these shares is 4,987,659,065.

Information about our previous General Meetings is available from the General Meeting archive tab above.